and it's dead. biib is such an exciting company; I would 6think there would be more of an exchange here. Well, let me put in my 2 cents. stock is basing here and consolidating. biotechs can move at any time. I would think this is a good spot to get started.
But, last week an approval for the hemophilia long acting drug, and another successful phase 3 report today, and stock goes down. Still, the pps did recover from the fall to 280. In a few months we will be OK.